News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
695,852 Results
Type
Article (55423)
Company Profile (161)
Press Release (640259)
Multimedia
Podcasts (111)
Webinars (21)
Section
Business (188693)
Career Advice (2758)
Deals (34507)
Drug Delivery (112)
Drug Development (77616)
Employer Resources (158)
FDA (16029)
Job Trends (14786)
News (325050)
Policy (30763)
Tag
Academia (2612)
Academic (2)
Accelerated approval (17)
Adcomms (26)
Allergies (121)
Alliances (49113)
ALS (135)
Alzheimer's disease (1473)
Antibody-drug conjugate (ADC) (223)
Approvals (16140)
Artificial intelligence (445)
Autoimmune disease (89)
Automation (28)
Bankruptcy (313)
Best Places to Work (11561)
BIOSECURE Act (17)
Biosimilars (149)
Biotechnology (106)
Bladder cancer (130)
Brain cancer (48)
Breast cancer (478)
Cancer (3799)
Cardiovascular disease (301)
Career advice (2353)
Career pathing (36)
CAR-T (238)
CDC (42)
Cell therapy (644)
Cervical cancer (31)
Clinical research (65197)
Collaboration (1331)
Company closure (4)
Compensation (641)
Complete response letters (45)
COVID-19 (2594)
CRISPR (81)
C-suite (602)
Cystic fibrosis (132)
Data (4579)
Decentralized trials (2)
Denatured (43)
Depression (95)
Diabetes (399)
Diagnostics (6704)
Digital health (35)
Diversity (12)
Diversity, equity & inclusion (40)
Drug discovery (202)
Drug pricing (156)
Drug shortages (28)
Duchenne muscular dystrophy (175)
Earnings (70099)
Editorial (49)
Employer branding (19)
Employer resources (140)
Events (106871)
Executive appointments (984)
FDA (18520)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (5)
Frontotemporal dementia (15)
Funding (1208)
Gene editing (171)
Generative AI (39)
Gene therapy (485)
GLP-1 (823)
Government (4666)
Grass and pollen (8)
Guidances (368)
Healthcare (18860)
HIV (43)
Huntington's disease (32)
IgA nephropathy (54)
Immunology and inflammation (194)
Immuno-oncology (14)
Indications (56)
Infectious disease (2810)
Inflammatory bowel disease (171)
Inflation Reduction Act (13)
Influenza (95)
Intellectual property (192)
Interviews (528)
IPO (15777)
IRA (45)
Job creations (3607)
Job search strategy (1956)
Kidney cancer (16)
Labor market (66)
Layoffs (578)
Leadership (33)
Legal (6994)
Liver cancer (84)
Longevity (12)
Lung cancer (534)
Lymphoma (251)
Machine learning (30)
Management (56)
Manufacturing (577)
MASH (128)
Medical device (14220)
Medtech (14245)
Mergers & acquisitions (19653)
Metabolic disorders (980)
Multiple sclerosis (128)
NASH (14)
Neurodegenerative disease (184)
Neuropsychiatric disorders (48)
Neuroscience (2412)
NextGen: Class of 2025 (6645)
Non-profit (4325)
Now hiring (25)
Obesity (438)
Opinion (278)
Ovarian cancer (135)
Pain (156)
Pancreatic cancer (164)
Parkinson's disease (222)
Partnered (27)
Patents (414)
Patient recruitment (330)
Peanut (56)
People (61040)
Pharmaceutical (35)
Pharmacy benefit managers (22)
Phase I (20680)
Phase II (28781)
Phase III (20994)
Pipeline (2676)
Policy (235)
Postmarket research (2329)
Preclinical (8786)
Press Release (70)
Prostate cancer (195)
Psychedelics (36)
Radiopharmaceuticals (271)
Rare diseases (605)
Real estate (6289)
Recruiting (65)
Regulatory (22494)
Reports (40)
Research institute (2350)
Resumes & cover letters (414)
Rett syndrome (16)
RNA editing (13)
RSV (63)
Schizophrenia (123)
Series A (206)
Series B (148)
Service/supplier (12)
Sickle cell disease (72)
Special edition (15)
Spinal muscular atrophy (147)
Sponsored (36)
Startups (3661)
State (2)
Stomach cancer (9)
Supply chain (76)
Tariffs (65)
The Weekly (66)
Vaccines (900)
Venture capital (55)
Weight loss (277)
Women's health (50)
Worklife (20)
Date
Last 7 days (712)
Last 30 days (2532)
Last 365 days (29913)
2025 (24875)
2024 (33963)
2023 (38429)
2022 (49397)
2021 (54249)
2020 (53076)
2019 (46901)
2018 (35681)
2017 (32432)
2016 (31802)
2015 (37456)
2014 (30267)
2013 (26421)
2012 (27990)
2011 (28274)
2010 (26650)
Location
Africa (888)
Alabama (75)
Alaska (7)
Arizona (227)
Arkansas (13)
Asia (41308)
Australia (7288)
California (8799)
Canada (2742)
China (853)
Colorado (381)
Connecticut (395)
Delaware (267)
Europe (94344)
Florida (1337)
Georgia (302)
Hawaii (2)
Idaho (61)
Illinois (744)
India (50)
Indiana (428)
Iowa (17)
Japan (325)
Kansas (118)
Kentucky (35)
Louisiana (18)
Maine (69)
Maryland (1188)
Massachusetts (6430)
Michigan (302)
Minnesota (549)
Mississippi (4)
Missouri (120)
Montana (32)
Nebraska (23)
Nevada (104)
New Hampshire (80)
New Jersey (2534)
New Mexico (30)
New York (2452)
North Carolina (1241)
North Dakota (9)
Northern California (4064)
Ohio (278)
Oklahoma (22)
Oregon (39)
Pennsylvania (1845)
Puerto Rico (19)
Rhode Island (39)
South America (1219)
South Carolina (51)
South Dakota (1)
Southern California (3420)
Tennessee (142)
Texas (1395)
United States (32541)
Utah (274)
Virginia (218)
Washington D.C. (63)
Washington State (764)
West Virginia (4)
Wisconsin (91)
Wyoming (1)
695,852 Results for "uci office of technology alliances ota".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
UCI Health Partner with Sierra Donor Services to Expand Kidney Transplant Opportunities Utilizing Paragonix KidneyVault Preservation Technology
May 29, 2025
·
4 min read
Autoimmune disease
Sanofi Joins With EVOQ in $500M Autoimmune Alliance
The partners have yet to disclose what their priority indications are, though EVOQ’s NanoDisc technology aims to enable the development of potentially curative treatments for autoimmune conditions such as celiac disease and type 1 diabetes.
October 16, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Nona Biosciences Appoints Dr. Di Hong as Chief Executive Officer to Drive Technology Innovation and Strategic Growth
October 14, 2025
·
4 min read
Press Releases
Three-year SPYRAL HTN-ON MED results show sustained, 18 mmHg office-based blood pressure reductions
October 27, 2025
·
4 min read
Press Releases
Advarra Appoints Brian Hart as Chief Technology Officer
August 5, 2025
·
2 min read
Press Releases
BioStem Technologies Appoints Brandon Poe as Chief Financial Officer
August 15, 2025
·
5 min read
Press Releases
BioDlink Strengthens Ecosystem Alliance to Empower Biotech Innovators Worldwide
- Alliance spans the full antibody drugs (mAbs/BsAbs), ADCs, fusion proteins, and other bioconjugates development and production lifecycle from bench to bedside and advances commercialization milestones - Alliance members include GlycanLink, Kexing Biopharm and industry chain partners, while innovative biotech clients include MediLink Therapeutics, Escugen and Smart Nuclide.
July 25, 2025
·
1 min read
Press Releases
BioGene Therapeutics Inc. Appoints Dr. Francis Tavares, PhD., as Chief Technology Officer
August 20, 2025
·
5 min read
Press Releases
Diakonos Oncology Expands Leadership Team with Appointment of Donna Rill as Chief Technology Officer
August 13, 2025
·
3 min read
Drug Development
Onward Therapeutics Announces Enrollment of Phase 1 Clinical Trial of a Novel Bispecific Antibody (OT-A201) Targeting Two Immune Checkpoints
Onward Therapeutics SA announced that the phase 1 clinical trial of OT-A201, a first-in-class bispecific antibody targeting two immune checkpoints is in progress.
January 24, 2024
·
3 min read
1 of 69,586
Next
